Meeting digital and technology standards, as well as cyber security standards in schools
Breathe Technology writes… even though it’s almost Christmas!
Monumo further strengthens management team and expands into US Market
Cambridge UK - Monumo, the company reinventing electric motors, has appointed Michael Horne as its Chief Commercial Officer.
Clinical considerations & payer perspectives
Late October saw the annual gathering of oncologists and industry in Madrid for ESMO 2023, bringing with it a wave of new clinical results across cancers and a fresh round of questions concerning pricing, access and reimbursement.
Monumo comes out of stealth to pitch at Deeptech Labs Demo Day
Cambridge UK: Monumo, the company reinventing electric motors, was delighted to emerge out of stealth mode and share its progress to over 300 investors at the Deeptech Labs Autumn 2023 Demo Day.
Evelyn Partners continues expansion of Cambridge office with two senior hires
Evelyn Partners, the leading integrated wealth management and professional services group, has bolstered its Cambridge office with the appointment of Mark Prince as an Audit Partner and Suzy Hawkey as Private Client Director.
Strategies for combination therapy in oncology: Part two - Working with the “status quo”
This is the second article in a three-part series examining the commercial dynamics surrounding combination therapy in oncology across the US and Europe.
Good business coaching is so powerful that if it were a drug it would be illegal
Chris Dunn writes..It’s use it or lose it time! But don't just spend your end-of-year budget, invest it for maximum return. And there's no better return than investing in executive coaching or business mentoring.
Brilliant impulse alumni continue to dazzle as application window for 2024 programme opens
ALUMNI of University of Cambridge’s hugely successful entrepreneurship and intrapreneurship programme, impulse continue to shine as the application window for the new 2024 intake opens.
Arm Extends Cortex-M Portfolio to Bring AI to the Smallest Endpoint Devices
By Paul Williamson, SVP and GM of the IoT LoB, Arm.
Antimicrobial Resistance Policy Solutions
It is difficult to imagine someone who hasn’t called on antibiotics to help them through an infection or protect them during a surgery. Thanks to developments over the last 150 years, once life-threatening bacterial encounters have been relegated to minor inconveniences. Or have they?
How well equipped are you to lead change?
Chris Dunn writes...Leading change is one of the most challenging aspects of leadership. This is not only because the pace of change is accelerating but also because so much seems to be changing all at the same time. So, where do leaders and senior managers get the right support to help them make more of the right calls about change management?
100 experts from Graphcore, Arm, Google and Stripe come together to support the next generation of Cambridge startups
Founders at the University of Cambridge opens applications to its first pre-seed accelerator.
Latest Greater Cambridge employment data showcases impressive economic strength and stability
The Greater Cambridge corporate economy significantly outperformed the national economy during the year ending in mid-February 2023. Corporate employment growth in the Greater Cambridge area surged from 6.0% in 2021-22 to an even more impressive 8.5% in 2022-23. Robust
Arm collaborates with Microsoft on custom Silicon to unlock sustainable, AI-driven infrastructure
By Mohamed Awad, SVP and GM of the Infrastructure Business, Arm.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial.
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space.
A longitudinal perspective on innovation
There is growing interest in the innovation process in the biopharmaceutical industry, with particular public scrutiny around the composition of research and development (R&D) spending and the role of intellectual property.
Oncology vaccines: Are they positioned for PMA success?
With combinations taking center stage following the initial influx of immune checkpoint inhibitor monotherapies, the authors look ahead to the potential of mRNA vaccines in oncology and describe the pricing and market access opportunities and challenges that may await current and future competito
Arm Holdings plc reports results for the second Quarter of the financial year ending 2024
Cambridge, UK: Arm Holdings plc (NASDAQ: ARM), the company that is building the future of computing, has recently published a letter to its shareholders containing the company’s results for its fiscal second quarter and three months ended September 30, 2023.
What to look for in an executive coach or business mentor
Not all executive coaches and business mentors are equal. The differences matter.
Successful employee engagement pilot on AI based app
Team Coaching Boutique writes..We have now completed the successful employee engagement pilot using our AI based development platform and the feedback was strong. A few snippet's are given below. A full testimonial is available on request or from the website.
Adopting AI: tips for managers implementing change
Firms are wrestling with how to convince staff to use artificial intelligence (AI) and other new technologies. A study led at Cambridge Judge, focusing on social comparisons among employees, cautions against a false dichotomy between full and no adoption.
The burden of non-specific pain disorder in US women
Based on existing evidence on the delay, lack of recognition, and burden of pain conditions commonly afflicting women (specifically endometriosis, PCOS, fibromyalgia, IBS or migraines), CRA sought to understand how being diagnosed with these conditions impacts women’s mental health and healthcare
The longitudinal history of medicines innovation: Part two
The second of a two-part article, CRA’s Life Sciences Practice team, along with experts at The Janssen Pharmaceutical Companies of Johnson & Johnson, recently conducted a landscape review of how complex pharmaceutical innovation happens in practice, leveraging three therapy area case studies: